Wentai Ma

This study identifies two broadly neutralizing antibodies against SARS-CoV-2 and related sarbecoviruses from individuals exposed only to ancestral SARS-CoV-2.

The paper compares SARS-CoV-2 variants from China and other countries, finding that Chinese variants have more dispersed RBD mutations with higher ACE2 binding and less immune evasion potential due to a distinct immune background.

The paper compares antibody responses from individuals with XBB reinfection and those vaccinated with WSK-V102C, showing the vaccine induces stronger neutralization against SARS-CoV-2 variants including JN.1 and BA.2.87.1.

This study evaluates the neutralization efficacy of a tetravalent vaccine booster against emerging SARS-CoV-2 variants, finding it induces higher neutralizing titers than breakthrough infection.

This study analyzes the genomic features of the SARS-CoV-2 Omicron variant, identifying its high mutation rate, spike protein alterations, and distinct evolutionary patterns.

This study uses hybrid capture sequencing to recover SARS-CoV-2 genomes from fecal samples, revealing dynamic intra-host variant changes and viral viability in the gastrointestinal tract during convalescence.